Global Hereditary Angioedema Therapeutic Market Growth (Status and Outlook) 2022-2028
- LP 4802817
- 89 Pages
- January 2022
- Pharmaceuticals
The United States Hereditary Angioedema Therapeutic market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Hereditary Angioedema Therapeutic market, reaching US$ million by the year 2028. As for the Europe Hereditary Angioedema Therapeutic landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Hereditary Angioedema Therapeutic players cover BioCryst Pharma, Ionis Pharma, Pharming Group, and CSL Limited, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Hereditary Angioedema Therapeutic market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Intravenous
Subcutaneous
Oral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals
Clinics
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size 2017-2028
2.1.2 Hereditary Angioedema Therapeutic Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Hereditary Angioedema Therapeutic Segment by Type
2.2.1 Intravenous
2.2.2 Subcutaneous
2.2.3 Oral
2.3 Hereditary Angioedema Therapeutic Market Size by Type
2.3.1 Hereditary Angioedema Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
2.4 Hereditary Angioedema Therapeutic Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Hereditary Angioedema Therapeutic Market Size by Application
2.5.1 Hereditary Angioedema Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
3 Hereditary Angioedema Therapeutic Market Size by Player
3.1 Hereditary Angioedema Therapeutic Market Size Market Share by Players
3.1.1 Global Hereditary Angioedema Therapeutic Revenue by Players (2020-2022)
3.1.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Players (2020-2022)
3.2 Global Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Hereditary Angioedema Therapeutic by Regions
4.1 Hereditary Angioedema Therapeutic Market Size by Regions (2017-2022)
4.2 Americas Hereditary Angioedema Therapeutic Market Size Growth (2017-2022)
4.3 APAC Hereditary Angioedema Therapeutic Market Size Growth (2017-2022)
4.4 Europe Hereditary Angioedema Therapeutic Market Size Growth (2017-2022)
4.5 Middle East & Africa Hereditary Angioedema Therapeutic Market Size Growth (2017-2022)
5 Americas
5.1 Americas Hereditary Angioedema Therapeutic Market Size by Country (2017-2022)
5.2 Americas Hereditary Angioedema Therapeutic Market Size by Type (2017-2022)
5.3 Americas Hereditary Angioedema Therapeutic Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Hereditary Angioedema Therapeutic Market Size by Region (2017-2022)
6.2 APAC Hereditary Angioedema Therapeutic Market Size by Type (2017-2022)
6.3 APAC Hereditary Angioedema Therapeutic Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Hereditary Angioedema Therapeutic by Country (2017-2022)
7.2 Europe Hereditary Angioedema Therapeutic Market Size by Type (2017-2022)
7.3 Europe Hereditary Angioedema Therapeutic Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Hereditary Angioedema Therapeutic by Region (2017-2022)
8.2 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2017-2022)
8.3 Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Hereditary Angioedema Therapeutic Market Forecast
10.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2023-2028)
10.1.1 Global Hereditary Angioedema Therapeutic Forecast by Regions (2023-2028)
10.1.2 Americas Hereditary Angioedema Therapeutic Forecast
10.1.3 APAC Hereditary Angioedema Therapeutic Forecast
10.1.4 Europe Hereditary Angioedema Therapeutic Forecast
10.1.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast
10.2 Americas Hereditary Angioedema Therapeutic Forecast by Country (2023-2028)
10.2.1 United States Hereditary Angioedema Therapeutic Market Forecast
10.2.2 Canada Hereditary Angioedema Therapeutic Market Forecast
10.2.3 Mexico Hereditary Angioedema Therapeutic Market Forecast
10.2.4 Brazil Hereditary Angioedema Therapeutic Market Forecast
10.3 APAC Hereditary Angioedema Therapeutic Forecast by Region (2023-2028)
10.3.1 China Hereditary Angioedema Therapeutic Market Forecast
10.3.2 Japan Hereditary Angioedema Therapeutic Market Forecast
10.3.3 Korea Hereditary Angioedema Therapeutic Market Forecast
10.3.4 Southeast Asia Hereditary Angioedema Therapeutic Market Forecast
10.3.5 India Hereditary Angioedema Therapeutic Market Forecast
10.3.6 Australia Hereditary Angioedema Therapeutic Market Forecast
10.4 Europe Hereditary Angioedema Therapeutic Forecast by Country (2023-2028)
10.4.1 Germany Hereditary Angioedema Therapeutic Market Forecast
10.4.2 France Hereditary Angioedema Therapeutic Market Forecast
10.4.3 UK Hereditary Angioedema Therapeutic Market Forecast
10.4.4 Italy Hereditary Angioedema Therapeutic Market Forecast
10.4.5 Russia Hereditary Angioedema Therapeutic Market Forecast
10.5 Middle East & Africa Hereditary Angioedema Therapeutic Forecast by Region (2023-2028)
10.5.1 Egypt Hereditary Angioedema Therapeutic Market Forecast
10.5.2 South Africa Hereditary Angioedema Therapeutic Market Forecast
10.5.3 Israel Hereditary Angioedema Therapeutic Market Forecast
10.5.4 Turkey Hereditary Angioedema Therapeutic Market Forecast
10.5.5 GCC Countries Hereditary Angioedema Therapeutic Market Forecast
10.6 Global Hereditary Angioedema Therapeutic Forecast by Type (2023-2028)
10.7 Global Hereditary Angioedema Therapeutic Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 BioCryst Pharma
11.1.1 BioCryst Pharma Company Information
11.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
11.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 BioCryst Pharma Main Business Overview
11.1.5 BioCryst Pharma Latest Developments
11.2 Ionis Pharma
11.2.1 Ionis Pharma Company Information
11.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
11.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ionis Pharma Main Business Overview
11.2.5 Ionis Pharma Latest Developments
11.3 Pharming Group
11.3.1 Pharming Group Company Information
11.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Offered
11.3.3 Pharming Group Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Pharming Group Main Business Overview
11.3.5 Pharming Group Latest Developments
11.4 CSL Limited
11.4.1 CSL Limited Company Information
11.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Offered
11.4.3 CSL Limited Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 CSL Limited Main Business Overview
11.4.5 CSL Limited Latest Developments
11.5 Shire
11.5.1 Shire Company Information
11.5.2 Shire Hereditary Angioedema Therapeutic Product Offered
11.5.3 Shire Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Shire Main Business Overview
11.5.5 Shire Latest Developments
11.6 Attune Pharma
11.6.1 Attune Pharma Company Information
11.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Offered
11.6.3 Attune Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Attune Pharma Main Business Overview
11.6.5 Attune Pharma Latest Developments
11.7 Adverum Biotechnologies
11.7.1 Adverum Biotechnologies Company Information
11.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
11.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Adverum Biotechnologies Main Business Overview
11.7.5 Adverum Biotechnologies Latest Developments
11.8 KalVista Pharma
11.8.1 KalVista Pharma Company Information
11.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
11.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 KalVista Pharma Main Business Overview
11.8.5 KalVista Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Hereditary Angioedema Therapeutic Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Intravenous
Table 3. Major Players of Subcutaneous
Table 4. Major Players of Oral
Table 5. Hereditary Angioedema Therapeutic Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
Table 8. Hereditary Angioedema Therapeutic Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
Table 11. Global Hereditary Angioedema Therapeutic Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player (2020-2022)
Table 13. Hereditary Angioedema Therapeutic Key Players Head office and Products Offered
Table 14. Hereditary Angioedema Therapeutic Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Hereditary Angioedema Therapeutic Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2017-2022)
Table 19. Americas Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Country (2017-2022)
Table 21. Americas Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
Table 23. Americas Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
Table 25. APAC Hereditary Angioedema Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region (2017-2022)
Table 27. APAC Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
Table 29. APAC Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
Table 31. Europe Hereditary Angioedema Therapeutic Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country (2017-2022)
Table 33. Europe Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
Table 35. Europe Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Hereditary Angioedema Therapeutic Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Hereditary Angioedema Therapeutic
Table 44. Key Market Challenges & Risks of Hereditary Angioedema Therapeutic
Table 45. Key Industry Trends of Hereditary Angioedema Therapeutic
Table 46. Global Hereditary Angioedema Therapeutic Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Hereditary Angioedema Therapeutic Market Size Market Share Forecast by Application (2023-2028)
Table 52. BioCryst Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 53. BioCryst Pharma Hereditary Angioedema Therapeutic Product Offered
Table 54. BioCryst Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. BioCryst Pharma Main Business
Table 56. BioCryst Pharma Latest Developments
Table 57. Ionis Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 58. Ionis Pharma Hereditary Angioedema Therapeutic Product Offered
Table 59. Ionis Pharma Main Business
Table 60. Ionis Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Ionis Pharma Latest Developments
Table 62. Pharming Group Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 63. Pharming Group Hereditary Angioedema Therapeutic Product Offered
Table 64. Pharming Group Main Business
Table 65. Pharming Group Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Pharming Group Latest Developments
Table 67. CSL Limited Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 68. CSL Limited Hereditary Angioedema Therapeutic Product Offered
Table 69. CSL Limited Main Business
Table 70. CSL Limited Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. CSL Limited Latest Developments
Table 72. Shire Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 73. Shire Hereditary Angioedema Therapeutic Product Offered
Table 74. Shire Main Business
Table 75. Shire Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Shire Latest Developments
Table 77. Attune Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 78. Attune Pharma Hereditary Angioedema Therapeutic Product Offered
Table 79. Attune Pharma Main Business
Table 80. Attune Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Attune Pharma Latest Developments
Table 82. Adverum Biotechnologies Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 83. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Offered
Table 84. Adverum Biotechnologies Main Business
Table 85. Adverum Biotechnologies Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Adverum Biotechnologies Latest Developments
Table 87. KalVista Pharma Details, Company Type, Hereditary Angioedema Therapeutic Area Served and Its Competitors
Table 88. KalVista Pharma Hereditary Angioedema Therapeutic Product Offered
Table 89. KalVista Pharma Main Business
Table 90. KalVista Pharma Hereditary Angioedema Therapeutic Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. KalVista Pharma Latest Developments
List of Figures
Figure 1. Hereditary Angioedema Therapeutic Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Hereditary Angioedema Therapeutic Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2021
Figure 7. Hereditary Angioedema Therapeutic in Hospitals
Figure 8. Global Hereditary Angioedema Therapeutic Market: Hospitals (2017-2022) & ($ Millions)
Figure 9. Hereditary Angioedema Therapeutic in Clinics
Figure 10. Global Hereditary Angioedema Therapeutic Market: Clinics (2017-2022) & ($ Millions)
Figure 11. Hereditary Angioedema Therapeutic in Others
Figure 12. Global Hereditary Angioedema Therapeutic Market: Others (2017-2022) & ($ Millions)
Figure 13. Global Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2021
Figure 14. Global Hereditary Angioedema Therapeutic Revenue Market Share by Player in 2021
Figure 15. Global Hereditary Angioedema Therapeutic Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Hereditary Angioedema Therapeutic Market Size 2017-2022 ($ Millions)
Figure 17. APAC Hereditary Angioedema Therapeutic Market Size 2017-2022 ($ Millions)
Figure 18. Europe Hereditary Angioedema Therapeutic Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2017-2022 ($ Millions)
Figure 20. Americas Hereditary Angioedema Therapeutic Value Market Share by Country in 2021
Figure 21. Americas Hereditary Angioedema Therapeutic Consumption Market Share by Type in 2021
Figure 22. Americas Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2021
Figure 23. United States Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Region in 2021
Figure 28. APAC Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2021
Figure 29. China Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Country in 2021
Figure 36. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2021
Figure 37. Europe Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2021
Figure 38. Germany Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Hereditary Angioedema Therapeutic Market Size Market Share by Application in 2021
Figure 46. Egypt Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Hereditary Angioedema Therapeutic Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 52. APAC Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 53. Europe Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 55. United States Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 56. Canada Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 59. China Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 60. Japan Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 61. Korea Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 63. India Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 64. Australia Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 65. Germany Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 66. France Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 67. UK Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 68. Italy Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 69. Russia Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 70. Spain Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 73. Israel Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Hereditary Angioedema Therapeutic Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
